Carlyle’s Curia in Talks to Buy LakePharma, Integrity Bio

44
6
Favorite

Carlyle’s Curia in Talks to Buy LakePharma, Integrity Bio

Bloomberg2021-07-13

Curia, a company backed by private equity firmsCarlyle Group Inc.andGTCRthat does contract research and development work for drugmakers, is in talks to acquire two smaller rivals, LakePharma ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（6）

Charlotte26
·2021-07-13
Like
Reply
1
Report
ac1887
·2021-07-13
good
Reply
3
Report
Fold Replies
- iewniy:
  ??
  2021-07-13
  Reply
  Report
Adollar
·2021-07-13
More acquisitions
Reply
5
Report
AdrinaChow
·2021-07-13
Like
Reply
5
Report
tyng8825
·2021-07-13
Good
Reply
3
Report
yyhwin12345
·2021-07-13
Hi
Reply
3
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1175534160?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-07-13 09:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1175534160","market":"us","top_or_hot":-1,"title":"Carlyle’s Curia in Talks to Buy LakePharma, Integrity Bio","media":"Bloomberg","content":"<div>\n<p>Curia, a company backed by private equity firmsCarlyle Group Inc.andGTCRthat does contract research and development work for drugmakers, is in talks to acquire two smaller rivals, LakePharma ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-07-13/carlyle-s-curia-said-in-talks-to-buy-lakepharma-integrity-bio?srnd=markets-vp\">Source Link</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Carlyle’s Curia in Talks to Buy LakePharma, Integrity Bio</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCarlyle’s Curia in Talks to Buy LakePharma, Integrity Bio\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-13 09:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-07-13/carlyle-s-curia-said-in-talks-to-buy-lakepharma-integrity-bio?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Curia, a company backed by private equity firmsCarlyle Group Inc.andGTCRthat does contract research and development work for drugmakers, is in talks to acquire two smaller rivals, LakePharma ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-07-13/carlyle-s-curia-said-in-talks-to-buy-lakepharma-integrity-bio?srnd=markets-vp\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CG","symbol_name":"凯雷","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2021-07-13/carlyle-s-curia-said-in-talks-to-buy-lakepharma-integrity-bio?srnd=markets-vp","article_id":"1175534160","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1175534160","pubTimestamp":1626140758,"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Curia, a company backed by private equity firmsCarlyle Group Inc.andGTCRthat does contract research ","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"CG":"凯雷"},"translate_title":"凯雷的库里亚正在谈判收购LakePharma和Integrity Bio","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CG":0.9},"content_text":"Curia, a company backed by private equity firmsCarlyle Group Inc.andGTCRthat does contract research and development work for drugmakers, is in talks to acquire two smaller rivals, LakePharma andIntegrity Bio, according to people with knowledge of the matter.\nThe two transactions, which could be announced as soon as this week, are expected to collectively be worth more than $500 million, including debt, said the people, who asked not to be identified because the information was private.\nFinal agreements haven’t been reached and talks could still fall apart, the people said.\nA spokesperson for Curia said the company routinely evaluates organic and inorganic investments, though it hasn’t announced any news at this time. Carlyle and GTCR declined to comment. Representatives for LakePharma and Integrity Bio didn’t immediately respond to requests for comment.\nCuria, based in Albany, New York, is a global contract research, development and manufacturing service provider to the pharmaceutical and biopharmaceutical industries. It changed its name fromAlbany Molecular Research Inc., or AMRI, according to astatementthis week.\n“The name Curia is derived from a Latin word for purposeful assembly and references Curia’s patient-inspired mission,” the company, led by Chairman and CEO John Ratliff, said in the statement. Curia said it has 564 active patents and produces more than 20 treatments included on the list of essential medicines from the World Health Organization.\nCuria agreed in 2017 to betaken privatein a transaction led by affiliates of Washington-based Carlyle and Chicago-based GTCR. The company has about $965 million in debt, according to data compiled by Bloomberg.\nBoth LakePharma and Integrity Bio provide services to biotechnology companies to help create medicines and treatments.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":142822709,"gmtCreate":1626141928501,"gmtModify":1703754161292,"author":{"id":"3566691395182663","authorId":"3566691395182663","name":"Charlotte26","avatar":"https://static.tigerbbs.com/4422950921a0d5cc669636bc539f0f0d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3566691395182663","idStr":"3566691395182663"},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/142822709","repostId":1175534160,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":142868350,"gmtCreate":1626141434770,"gmtModify":1703754142299,"author":{"id":"3585352116267703","authorId":"3585352116267703","name":"ac1887","avatar":"https://static.tigerbbs.com/a4f5865f79452e7da123e88ff35959e5","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3585352116267703","idStr":"3585352116267703"},"htmlText":"good","listText":"good","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/142868350","repostId":1175534160,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5202413,"gmtCreate":1626141453367,"gmtModify":1663230891751,"authorId":3586313117343887,"author":{"id":3586313117343887,"idStr":"3586313117343887","authorId":3586313117343887,"name":"iewniy","avatar":"https://static.tigerbbs.com/7ec5097db3200c1ada16ba11791d895b","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":142868350,"type":1,"supId":0,"prevId":0,"content":"??","text":"??","html":"??"}],"langContent":"EN"},{"id":142868049,"gmtCreate":1626141421981,"gmtModify":1703754141812,"author":{"id":"3582843618871796","authorId":"3582843618871796","name":"Adollar","avatar":"https://static.tigerbbs.com/0b7c3e8d0ea455e203fda09d0d2cffb8","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3582843618871796","idStr":"3582843618871796"},"htmlText":"More acquisitions&nbsp;","listText":"More acquisitions&nbsp;","text":"More acquisitions","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/142868049","repostId":1175534160,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":142863396,"gmtCreate":1626141298315,"gmtModify":1703754138391,"author":{"id":"3583131237618472","authorId":"3583131237618472","name":"AdrinaChow","avatar":"https://static.tigerbbs.com/d1b867f4c2019d6ec313665b1af8431b","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3583131237618472","idStr":"3583131237618472"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/142863396","repostId":1175534160,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":142860327,"gmtCreate":1626141169569,"gmtModify":1703754136083,"author":{"id":"3570852047190387","authorId":"3570852047190387","name":"tyng8825","avatar":"https://static.tigerbbs.com/96881c116505f25bd9b7404b76c5e06d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3570852047190387","idStr":"3570852047190387"},"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/142860327","repostId":1175534160,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":142886253,"gmtCreate":1626140969672,"gmtModify":1703754129110,"author":{"id":"3586228965364851","authorId":"3586228965364851","name":"yyhwin12345","avatar":"https://static.tigerbbs.com/f73f48f7dbf02904c9a179fb59cc138d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586228965364851","idStr":"3586228965364851"},"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/142886253","repostId":1175534160,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":44,"commentSize":6,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}